Cargando…
Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives
SIMPLE SUMMARY: Subtotal resection of the esophagus with resection of local lymph nodes is the oncological procedure of choice for advanced esophageal cancer. Reconstruction of the intestinal tract is predominantly performed with a gastric tube. Even in specialized centers, this surgical procedure i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616112/ https://www.ncbi.nlm.nih.gov/pubmed/34830988 http://dx.doi.org/10.3390/cancers13225834 |
_version_ | 1784604269226229760 |
---|---|
author | Schröder, Wolfgang Gisbertz, Suzanne S. Voeten, Daan M. Gutschow, Christian A. Fuchs, Hans F. van Berge Henegouwen, Mark I. |
author_facet | Schröder, Wolfgang Gisbertz, Suzanne S. Voeten, Daan M. Gutschow, Christian A. Fuchs, Hans F. van Berge Henegouwen, Mark I. |
author_sort | Schröder, Wolfgang |
collection | PubMed |
description | SIMPLE SUMMARY: Subtotal resection of the esophagus with resection of local lymph nodes is the oncological procedure of choice for advanced esophageal cancer. Reconstruction of the intestinal tract is predominantly performed with a gastric tube. Even in specialized centers, this surgical procedure is associated with a high complication but low mortality rate. Therefore, clinical research aims to develop peri- and intra-operative strategies to improve the patient related outcome. ABSTRACT: Transthoracic esophagectomy is currently the predominant curative treatment option for resectable esophageal adenocarcinoma. The majority of carcinomas present as locally advanced tumors requiring multimodal strategies with either neoadjuvant chemoradiotherapy or perioperative chemotherapy alone. Minimally invasive, including robotic, techniques are increasingly applied with a broad spectrum of technical variations existing for the oncological resection as well as gastric reconstruction. At the present, intrathoracic esophagogastrostomy is the preferred technique of reconstruction (Ivor Lewis esophagectomy). With standardized surgical procedures, a complete resection of the primary tumor can be achieved in almost 95% of patients. Even in expert centers, postoperative morbidity remains high, with an overall complication rate of 50–60%, whereas 30- and 90-day mortality are reported to be <2% and <6%, respectively. Due to the complexity of transthoracic esophagetomy and its associated morbidity, esophageal surgery is recommended to be performed in specialized centers with an appropriate caseload yet to be defined. In order to reduce postoperative morbidity, the selection of patients, preoperative rehabilitation and postoperative fast-track concepts are feasible strategies of perioperative management. Future directives aim to further centralize esophageal services, to individualize surgical treatment for high-risk patients and to implement intraoperative imaging modalities modifying the oncological extent of resection and facilitating surgical reconstruction. |
format | Online Article Text |
id | pubmed-8616112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86161122021-11-26 Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives Schröder, Wolfgang Gisbertz, Suzanne S. Voeten, Daan M. Gutschow, Christian A. Fuchs, Hans F. van Berge Henegouwen, Mark I. Cancers (Basel) Review SIMPLE SUMMARY: Subtotal resection of the esophagus with resection of local lymph nodes is the oncological procedure of choice for advanced esophageal cancer. Reconstruction of the intestinal tract is predominantly performed with a gastric tube. Even in specialized centers, this surgical procedure is associated with a high complication but low mortality rate. Therefore, clinical research aims to develop peri- and intra-operative strategies to improve the patient related outcome. ABSTRACT: Transthoracic esophagectomy is currently the predominant curative treatment option for resectable esophageal adenocarcinoma. The majority of carcinomas present as locally advanced tumors requiring multimodal strategies with either neoadjuvant chemoradiotherapy or perioperative chemotherapy alone. Minimally invasive, including robotic, techniques are increasingly applied with a broad spectrum of technical variations existing for the oncological resection as well as gastric reconstruction. At the present, intrathoracic esophagogastrostomy is the preferred technique of reconstruction (Ivor Lewis esophagectomy). With standardized surgical procedures, a complete resection of the primary tumor can be achieved in almost 95% of patients. Even in expert centers, postoperative morbidity remains high, with an overall complication rate of 50–60%, whereas 30- and 90-day mortality are reported to be <2% and <6%, respectively. Due to the complexity of transthoracic esophagetomy and its associated morbidity, esophageal surgery is recommended to be performed in specialized centers with an appropriate caseload yet to be defined. In order to reduce postoperative morbidity, the selection of patients, preoperative rehabilitation and postoperative fast-track concepts are feasible strategies of perioperative management. Future directives aim to further centralize esophageal services, to individualize surgical treatment for high-risk patients and to implement intraoperative imaging modalities modifying the oncological extent of resection and facilitating surgical reconstruction. MDPI 2021-11-21 /pmc/articles/PMC8616112/ /pubmed/34830988 http://dx.doi.org/10.3390/cancers13225834 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Schröder, Wolfgang Gisbertz, Suzanne S. Voeten, Daan M. Gutschow, Christian A. Fuchs, Hans F. van Berge Henegouwen, Mark I. Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives |
title | Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives |
title_full | Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives |
title_fullStr | Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives |
title_full_unstemmed | Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives |
title_short | Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives |
title_sort | surgical therapy of esophageal adenocarcinoma—current standards and future perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616112/ https://www.ncbi.nlm.nih.gov/pubmed/34830988 http://dx.doi.org/10.3390/cancers13225834 |
work_keys_str_mv | AT schroderwolfgang surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives AT gisbertzsuzannes surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives AT voetendaanm surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives AT gutschowchristiana surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives AT fuchshansf surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives AT vanbergehenegouwenmarki surgicaltherapyofesophagealadenocarcinomacurrentstandardsandfutureperspectives |